{"news_desk": "Foreign", "print_page": "3", "section_name": "Health", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Tekmira Pharmaceuticals says experimental Ebola drug it has been developing, called TKM-Ebola-Guinea, has not worked on patients in Sierra Leone, dealing setback to what was considered promising new treatment.", "type_of_material": "News", "word_count": "427", "lead_paragraph": "Tekmira Pharmaceuticals announced Friday that the trial of TKM-Ebola-Guinea had been stopped because it did not demonstrate a therapeutic benefit.", "pub_date": "2015-06-20T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Clinical Trial of Experimental Ebola Drug Is Halted", "print_headline": "Setback as Ebola Drug Trial Is Halted"}, "snippet": "Tekmira Pharmaceuticals announced Friday that the trial of TKM-Ebola-Guinea had been stopped because it did not demonstrate a therapeutic benefit.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/06/20/health/clinical-trial-of-experimental-ebola-drug-is-halted.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Ebola Virus", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Tekmira Pharmaceuticals Corporation", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Sierra Leone", "name": "glocations"}, {"rank": "5", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Medicine and Health", "name": "subject"}], "blog": [], "_id": "55844af438f0d873a5d4afdb", "source": "The New York Times"}